182 related articles for article (PubMed ID: 16894300)
1. Controversies in the management of germ cell tumours of the ovary.
Patterson DM; Rustin GJ
Curr Opin Oncol; 2006 Sep; 18(5):500-6. PubMed ID: 16894300
[TBL] [Abstract][Full Text] [Related]
2. Germ cell tumors of the ovary.
Pectasides D; Pectasides E; Kassanos D
Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
[TBL] [Abstract][Full Text] [Related]
3. Ovarian germ cell tumours: a 17-year study in a single unit.
Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
[TBL] [Abstract][Full Text] [Related]
4. Management of ovarian germ cell tumours.
Newlands ES
Forum (Genova); 2000; 10(4):368-80. PubMed ID: 11535986
[TBL] [Abstract][Full Text] [Related]
5. Ovarian stromal and germ cell tumors.
Koulouris CR; Penson RT
Semin Oncol; 2009 Apr; 36(2):126-36. PubMed ID: 19332247
[TBL] [Abstract][Full Text] [Related]
6. Current controversies in the management of germ cell ovarian tumours.
Vazquez I; Rustin GJ
Curr Opin Oncol; 2013 Sep; 25(5):539-45. PubMed ID: 23942298
[TBL] [Abstract][Full Text] [Related]
7. Surgery of germ cell tumours of the ovary.
Schwartz PE
Forum (Genova); 2000; 10(4):355-65. PubMed ID: 11535985
[TBL] [Abstract][Full Text] [Related]
8. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
9. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract][Full Text] [Related]
10. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
11. Management of malignant ovarian germ cell tumors.
Parkinson CA; Hatcher HM; Ajithkumar TV
Obstet Gynecol Surv; 2011 Aug; 66(8):507-14. PubMed ID: 22018453
[TBL] [Abstract][Full Text] [Related]
12. Management of clinical stage I nonseminomatous germ cell testicular cancer.
Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
[TBL] [Abstract][Full Text] [Related]
13. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
Malagón HD; Valdez AM; Moran CA; Suster S
Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
[TBL] [Abstract][Full Text] [Related]
14. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
Cao D; Humphrey PA; Allan RW
Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862
[TBL] [Abstract][Full Text] [Related]
15. Current management of stage I testicular non-seminomatous germ cell tumours.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
[TBL] [Abstract][Full Text] [Related]
16. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
[TBL] [Abstract][Full Text] [Related]
17. Histogenetic analysis of ovarian germ cell tumors by DNA fingerprinting.
Inoue M; Fujita M; Azuma C; Saji F; Tanizawa O
Cancer Res; 1992 Dec; 52(24):6823-6. PubMed ID: 1360871
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour markers in ovarian tumours.
von Schlippe M; Rustin GJ
Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
[TBL] [Abstract][Full Text] [Related]
19. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
20. [Malignant ovarian germ cell tumours: a trial of 36 cases].
Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]